論文

査読有り 国際誌
2020年1月10日

Identifying signatures of the impact of rotavirus vaccines on hospitalizations using sentinel surveillance data from Latin American countries.

Vaccine
  • Kayoko Shioda
  • ,
  • Lucia Helena de Oliveira
  • ,
  • Jennifer Sanwogou
  • ,
  • Gloria Rey-Benito
  • ,
  • Diana Nuñez Azzad
  • ,
  • Roxana Elizabeth Castillo
  • ,
  • María Liz Gamarra Ramírez
  • ,
  • Marta Raquel Von Horoch
  • ,
  • Daniel M Weinberger
  • ,
  • Virginia E Pitzer

38
2
開始ページ
323
終了ページ
329
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1016/j.vaccine.2019.10.010

BACKGROUND: Passive surveillance data are often the only available source of data that can be used to evaluate the population-level impact of vaccination, but such data often suffer from important limitations such as changes in surveillance efforts. This study provides an example of how to identify important signatures of rotavirus vaccine impact, including evaluating the overall effectiveness and changes in rotavirus seasonal dynamics. METHODS: We used data from a standardized sentinel rotavirus surveillance network in six Latin American countries (Bolivia, El Salvador, Guatemala, Honduras, Paraguay, and Venezuela) from 2004 to 2017. A random-effects model was used to evaluate changes in the proportion of rotavirus-associated hospitalizations following vaccine introduction. Harmonic regression models were used to estimate vaccine impact on the number of rotavirus hospitalizations, controlling for trends in rotavirus-negative cases. Changes to rotavirus seasonality were evaluated using center of gravity analysis, wavelet analysis, and harmonic regression. RESULTS: All countries observed declines in the proportion of rotavirus-positive acute diarrhea samples with a mean reduction of 16% (95% confidence interval: 10-22%). We estimate that each 10% increase in vaccine coverage was associated with declines in the number of rotavirus-positive cases, ranging from 4.3% (1.3-7.2%) in Honduras to 21.4% (16.8-25.9%) in Venezuela. The strength of the seasonal peak in rotavirus incidence became smaller after vaccine introduction in Guatemala, Honduras, and Venezuela. Seasonal peaks also shifted later in the surveillance year, especially in higher-mortality countries. CONCLUSIONS: The combination of methods we applied have different strengths that allow us to identify common signatures of rotavirus vaccine impact.

リンク情報
DOI
https://doi.org/10.1016/j.vaccine.2019.10.010
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/31672333
ID情報
  • DOI : 10.1016/j.vaccine.2019.10.010
  • PubMed ID : 31672333

エクスポート
BibTeX RIS